Transcription of Public Assessment Report Decentralised Procedure …
{{id}} {{{paragraph}}}
Example: bankruptcy
Public Assessment Report Decentralised Procedure …
PAR Or listat Mylan 60 mg capsules, har d UK/H/5278/001/DC 1 Public Assessment Report Decentralised Procedure Orlistat Mylan 60 mg capsules, hard (Orlistat) Procedure No: UK/H/5278/001/DC UK Licence No: PL 04569/1359 Generics (UK) Limited (trading as Mylan) PAR Or listat Mylan 60 mg capsules, har d UK/H/5278/001/DC 2 LAY SUMMARY Orlistat Mylan 60 mg capsules, hard (orlistat, hard capsules, 60 mg) This is a summary of the Public Assessment Report (PAR) for Orlistat Mylan 60 mg capsules, hard (PL 04569/1359; UK/H/5278/001/DC). It explains how Orlistat Mylan 60 mg capsules, hard w as assessed and its authorisation recommended, as well as its conditions of use.
PAR Orlistat Mylan 60 mg capsules, hard UK/H/5278/001/DC 1. Public Assessment Report . Decentralised Procedure . Orlistat Mylan 60 mg capsules, hard (Orlistat) Procedure No: UK/H/5278/001/DC
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Assessment Guidance for Enzyme-Containing, ASSESSMENT, Enzyme, Guidance, 2.8.3 Allergen Cleaning and, 2.8.3 Allergen Cleaning and Sanitation Practices, HAZARD ASSESSMENT REPORT Hydrazine, Assessment Report, COMMITTEE ON HERBAL MEDICINAL PRODUCTS, Herbal medicinal products containing, EACO Lead Guideline, WORLD HEALTH ORGANIZATION